DE274931C - - Google Patents
Info
- Publication number
- DE274931C DE274931C DENDAT274931D DE274931DA DE274931C DE 274931 C DE274931 C DE 274931C DE NDAT274931 D DENDAT274931 D DE NDAT274931D DE 274931D A DE274931D A DE 274931DA DE 274931 C DE274931 C DE 274931C
- Authority
- DE
- Germany
- Prior art keywords
- wafer
- liquid
- core
- tasting
- wrapping
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 claims description 7
- 235000012431 wafers Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drugs Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 210000001736 Capillaries Anatomy 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001464 adherent Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000152 swallowing Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Description
KAISERLICHESIMPERIAL
PATENTAMT.PATENT OFFICE.
Das Einnehmen von unangenehm schmeckenden Arzneimitteln in Tropfenform hat in vielen Fällen den Nachteil, Erbrechen und Widerwillen hervorzurufen, die den therapeutischen Erfolg in Frage stellen. Dieser Mißstand bat zur Fabrikation von Kapseln usw. Veranlassung gegeben, welche die flüssigen Arzneimittel in fertig dosierter, leicht aufzubewahrender Form enthalten, die aber nur vonTaking unpleasant-tasting drugs in the form of drops has in in many cases the disadvantage of provoking vomiting and reluctance, which is therapeutic Question success. This deficiency prompted the manufacture of capsules, etc., which gave rise to the liquid ones Contains drugs in ready-to-use, easy-to-store form, but only from
ίο einer Fabrik oder vom Apotheker unter Benutzung besonderer Vorrichtungen hergestellt werden können.ίο a factory or by the pharmacist in use special devices can be produced.
Vorliegende Erfindung betrifft nun eine Oblate, die die Herstellung ähnlicher, geschmackfreier Präparate aus unangenehm schmeckenden Flüssigkeiten unmittelbar durch den Arzt, Krankenpfleger oder den Patienten selbst ermöglichen soll.The present invention now relates to a wafer that allows the production of similar, tasteless Make preparations from unpleasant-tasting liquids possible directly by the doctor, nurse or the patient himself target.
Es ist bereits vorgeschlagen worden, schlechtIt's been suggested badly
ao schmeckende flüssige Medikamente auf Zucker-, Kaffeepulver oder Mehl zu geben, die Masse dann in Oblaten zu hüllen und in dieser Form zu verschlucken (vgl. Pharmaz. Zentralhalle 1887, S. 229, Sp. 2). Hierbei besteht indessen der Ubelstand, daß das Hinüberbringen des pulverförmigen oder halbfesten Gemisches auf die Oblate und das Einhüllen der auf der Oblate nicht haftenden Masse in die mit Wasser benetzte Oblate umständlich ist. Diesem Ubelstande soll die Erfindung abhelfen. Sie besteht darin, daß die Oblate b selbst mit einem die Flüssigkeit aufnehmenden oder kapillar aufsaugenden Kern α aus Oblatenmasse oder einem ähnlich wirkenden Stoff versehen ist. Eine derartige Oblate kann nach Aufnähme der Arzneitropfen durch den Kern von außen mit Wasser befeuchtet, darauf geschlossen oder zugewickelt und verschluckt werden. Sie stellt also eine jederzeit gebrauchsfertige Vorrichtung dar, die es dem Arzt, Kranken-Wärter oder Patienten in einfachster Weise ohne jede Übung oder nennenswerte Zeit erfordernde Maßnahmen ermöglicht, z.B. bitter schmeckende Tropfen in eine geschmackfreie Form zu bringen. Der Kern α kann verschiedenartig ausgebildet werden, wie aus der Zeichnung zu ersehen ist. Er kann erforderlichenfalls zum Schutz gegen das Durchdringen der Flüssigkeit mittels einer sinngemäß angebrachten unlöslichen Schicht von Gelatine o. dgl. versehen werden.ao tasting liquid medication on sugar, coffee powder or flour, then wrapping the mass in wafers and swallowing it in this form (cf. Pharmaz. Zentralhalle 1887, p. 229, column 2). Here, however, there is the disadvantage that the transfer of the powdery or semi-solid mixture onto the wafer and the wrapping of the non-adherent mass in the wafer wetted with water is cumbersome. The invention is intended to remedy this disadvantage. It consists in the fact that the wafer b itself is provided with a core α made of wafer mass or a similarly acting substance which absorbs the liquid or absorbs the liquid by capillary action. Such a wafer can be moistened with water from the outside after the drug has been absorbed by the core, then closed or wound up and swallowed. It is therefore a ready-to-use device that enables the doctor, nurse or patient in the simplest way without any exercise or any significant time-consuming measures, for example to bring bitter-tasting drops into a tasteless form. The core α can be designed in various ways, as can be seen from the drawing. If necessary, it can be provided with an insoluble layer of gelatin or the like that is applied in a similar manner to protect against penetration of the liquid.
Claims (1)
Publications (1)
Publication Number | Publication Date |
---|---|
DE274931C true DE274931C (en) |
Family
ID=531258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT274931D Active DE274931C (en) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE274931C (en) |
-
0
- DE DENDAT274931D patent/DE274931C/de active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60126089T2 (en) | ADMINISTRATION SYSTEM | |
Sollmann | A manual of pharmacology and its applications to therapeutics and toxicology | |
DE69934831T2 (en) | MULTIPLEXES, MEDICAMENT DELIVERY SUITABLE FOR ORAL ADMINISTRATION | |
DE69732909T2 (en) | Rapidly disintegrating molding compound and process for its preparation | |
DE19835346A1 (en) | Two-part capsule for pharmaceutical preparations for powder inhalers | |
DE69317216T2 (en) | Device for dosing pharmaceutical, multi-dose syrup for preparation on the spot | |
DE69430580T2 (en) | MEDICINAL PRODUCTS IN FOOD FORM | |
Helfand et al. | Evolution of pharmaceutical oral dosage forms | |
CH661663A5 (en) | DOSAGE FOR DRUGS IN MICROCAPSULES WITH SUESSER MATRIX. | |
DE102017100042B4 (en) | Active substance-loadable absorbent piece, pacifier and use of a dosage form in a pacifier | |
US6165495A (en) | Drug delivery system | |
DE68928415T2 (en) | METHOD AND COMPOSITIONS FOR ADMINISTRATING LIPOPHILE MEDICINES IN A DOSAGE AFTER THE DESIRED EFFECT | |
DE274931C (en) | ||
DE10392164T5 (en) | Oral pharmaceutical formulation | |
DE202017006939U1 (en) | Cartridge for pacifier with inhalation device | |
DE2105110A1 (en) | Novel drug | |
EP1075253B1 (en) | Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use | |
Nikiforova et al. | Recipe of veterinary medicine | |
DE102017012248B3 (en) | SCHEULLER COMPREHENSIVELY A REPLACEABLE CARTRIDGE, AND USE OF A MEDICINE IN A PACIFIER | |
AU556989B2 (en) | Sustained release method and product | |
DE68922225T2 (en) | COMPRESSED POWDER MEDICAL. | |
WO1994025011A1 (en) | Drug delivery system | |
DE29719070U1 (en) | Blister for combination therapy | |
McWalter | A Note On The New" Pharmacopœia" | |
DE19716905C1 (en) | Aqueous L-selegilin solution for treating Parkinson's disease |